Bessemer Group
GPCR icon

Bessemer Group’s Structure Therapeutics GPCR Stock Holding History

Bessemer Group’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Buy
+22
New +$973 ﹤0.01% 2468
2026
Q1 		– Sell
-29
Closed -$2K – 2582
2025
Q4 		$2K Hold
29
– – ﹤0.01% 2414
2025
Q3 		$1K Buy
+29
New +$578 ﹤0.01% 2412

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Bessemer Group's GPCR Position: Q2 2026 in Review

Bessemer Group opened a new position in Structure Therapeutics (GPCR) in Q2 2026: 22 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #2468 among its holdings. This is a return to the name: Bessemer Group previously reported a position in GPCR as recently as Q4 2025.

Bessemer Group first reported a position in GPCR in Q3 2025 and has held it in 3 quarters since. The position peaked at $2K in Q4 2025. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Bessemer Group held 22 shares of Structure Therapeutics worth $1K as of Q2 2026.
  • Structure Therapeutics was a new Bessemer Group position in Q2 2026.
  • Structure Therapeutics made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #2468 holding.
  • Bessemer Group first reported a position in Structure Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Bessemer Group's Structure Therapeutics position peaked at $2K in Q4 2025.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.